Jade Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 23-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.23 Cr
as on 23-12-2024
- Revenue 3732.20%
(FY 2021)
- Profit 328.65%
(FY 2021)
- Ebitda 241.66%
(FY 2021)
- Net Worth 242.12%
(FY 2021)
- Total Assets 691.79%
(FY 2021)
About Jade Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹12.23 Cr.
Ramu Karthick and Sundaraj Kumar serve as directors at the Company.
- CIN/LLPIN
U51909TN2019PTC132614
- Company No.
132614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Jade Life Sciences Private Limited offer?
Jade Life Sciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Anti Allergic Drug, Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Antiemetic, Antibiotic Injection.
Who are the key members and board of directors at Jade Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundaraj Kumar  | Director | 12-Feb-2022 | Current |
| Ramu Karthick | Director | 12-Feb-2022 | Current |
Financial Performance of Jade Life Sciences.
Jade Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 3732.2% increase. The company also saw a substantial improvement in profitability, with a 328.65% increase in profit. The company's net worth Soared by an impressive increase of 242.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jade Life Sciences?
Unlock access to Jade Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jul 2024 | ₹2.73 Cr | Open |
Others Creation Date: 21 Feb 2023 | ₹9.50 Cr | Open |
How Many Employees Work at Jade Life Sciences?
Unlock and access historical data on people associated with Jade Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jade Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jade Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
